MedPath

LifeSenze EYEGARD Capsule

Registration Number: MAL22116106TC

Approved
Approval ID

b57fe23fe6b82136

Registration Number

MAL22116106TC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types6 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (6)

30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved
60 CapsulesAvailable
Package Size: 60 Capsules
Status: NPRA Approved
90 CapsulesAvailable
Package Size: 90 Capsules
Status: NPRA Approved
120 CapsulesAvailable
Package Size: 120 Capsules
Status: NPRA Approved
150 CapsulesAvailable
Package Size: 150 Capsules
Status: NPRA Approved
180 CapsulesAvailable
Package Size: 180 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (5)

Tagetes erectaActive
Monograph: tagetes erecta
Vaccinium myrtillusActive
Monograph: Bilberry
Lycium barbarumActive
Monograph: lycium barbarum
Euphrasia officinalisActive
Monograph: euphrasia officinalis
Haematococcus pluvialisActive
Monograph: haematococcus pluvialis

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LifeSenze EYEGARD Capsule - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform